Patients are Talking: Change is Needed in How We Manage Endometriosis

Target Audience
This educational activity is designed for clinicians who treat patients with EM (OB/GYNs, internists, primary care providers, nurses, and other healthcare professionals).

Program Overview
The average time to an endometriosis (EM) diagnosis continues to be a staggering 10 years, though this time may be even longer in women of color. Clinicians need to learn how to address these ongoing delays in EM care. Hear real patient stories and learn real-world strategies to reduce diagnostic delays, address treatment misconceptions, and navigate challenges in care that racially diverse women face at incomparable rates. Learn about the limitations with conventional EM treatment options and surgery as well as with the promising role of newer GnRH receptor antagonists in managing EM-related pain.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe the clinical and economic burden of EM
Explore how clinical and non-invasive tools may facilitate earlier diagnosis and treatment of EM and improve outcomes in diverse patients
Outline limitations with conventional treatment strategies for EM and review new opportunities with GnRH receptor antagonists
Evaluate the latest safety, efficacy, and clinical differentiators of the GnRH antagonists in improving long-term outcomes for EM management